Smith+Nephew Reports Strong FY2025 Results, Completes 12-Point Plan, and Initiates New Growth Strategy

summarizeSummary

Smith+Nephew reported strong full-year 2025 results, completed its 12-Point Plan, and launched a new RISE strategy with positive 2026 guidance, including a $500 million share buyback and dividend increase.

check_boxKey Events

• Full Year 2025 Financial Performance

  Reported 6.1% revenue growth to $6.16 billion, 20.7% operating profit increase to $794 million, and a 52.5% surge in free cash flow to $840 million, exceeding targets.

• Strategic Transformation Completed

  Successfully concluded the 12-Point Plan, strengthening operational foundations and launching the new RISE strategy with ambitious 2028 financial targets for accelerated growth and returns.

• Positive 2026 Outlook

  Forecasts underlying revenue growth of approximately 6% and trading profit of around $1.3 billion, with adjusted ROIC expected to exceed 10%.

• Shareholder Returns

  Completed a $500 million share buyback in H2 2025 and increased the full-year dividend by 4.3% to 39.1¢ per share.

auto_awesomeAnalysis

This 6-K details Smith+Nephew's robust financial performance for the full year 2025, exceeding revenue, profitability, and cash generation targets. The company successfully completed its 12-Point Plan, transforming into a stronger business, and launched its new RISE strategy with ambitious 2028 financial targets. The positive 2026 outlook, including accelerated revenue growth and increased trading profit, coupled with a significant $500 million share buyback and a dividend increase, signals strong operational momentum and a commitment to shareholder returns. Investors should note the long-term strategic direction and the expected accretion from the Integrity Orthopaedics acquisition by 2028.